<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid/><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid">PMC11335690</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcid-ver">PMC11335690.1</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaid">11335690</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmcaiid">11335690</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">39170078</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.3389/fneur.2024.1443496</article-id></all-ids><extracted-table><table-id>tab1</table-id><table-label>Table 1</table-label><table-caption>Socio-demographic, symptoms, and imaging measures for the two control groups (orthopedic control, OC, and healthy controls, HC).</table-caption><table-wrap-foot>Values shown are Mean ± SD, with ranges or percentage in (). Race includes White (W), Black or African American (B), Asian (A), and Other (O). PSQI is the global PSQI score using the Pittsburgh Sleep Quality Questionnaire. RPQ is the total scores from the Rivermead Post Concussion Symptoms questionnaire. Total number of symptoms was counted when reported as at least mild symptoms (RPQ ratings ≥2). WM-ePVS is the white matter ePVS burden. BG-PVS is the basal ganglia ePVS burden. Significant p-values (p &lt; 0.05) were shown in bold with *. MVC, Motor Vehicle Collision.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="tab1" orientation="portrait"><label>Table 1</label><caption><p>Socio-demographic, symptoms, and imaging measures for the two control groups (orthopedic control, OC, and healthy controls, HC).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" valign="top" rowspan="1" colspan="1">Orthopedic control</th><th align="center" valign="top" rowspan="1" colspan="1">Healthy control</th><th align="center" valign="top" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-value (OC vs. HC)</th></tr></thead><tbody><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">N</italic></td><td align="center" valign="bottom" rowspan="1" colspan="1">19</td><td align="center" valign="bottom" rowspan="1" colspan="1">18</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age (yrs)</td><td align="center" valign="middle" rowspan="1" colspan="1">37.3 ± 13.8 (19–60)</td><td align="center" valign="middle" rowspan="1" colspan="1">35.5 ± 12.3 (18–56)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.79</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Sex (Male)</td><td align="center" valign="bottom" rowspan="1" colspan="1">12 (63%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">5 (28%)</td><td align="center" valign="bottom" rowspan="1" colspan="1"><bold>0.043*</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Education (yrs)</td><td align="center" valign="middle" rowspan="1" colspan="1">13.4 ± 1.9 (11–18)</td><td align="center" valign="middle" rowspan="1" colspan="1">17.1 ± 3.4 (10–24)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.0003*</bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Race (W/B/A/O)</td><td align="center" valign="middle" rowspan="1" colspan="1">7/10/1/1</td><td align="center" valign="middle" rowspan="1" colspan="1">9/7/2/0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.55</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Body Mass Index (BMI)</td><td align="center" valign="middle" rowspan="1" colspan="1">28.3 ± 6.7 (20.7–53.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">28.7 ± 9.8 (19.5–53.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.87</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Days post injury</td><td align="center" valign="middle" rowspan="1" colspan="1">13.8 ± 6.9 (6–29)</td><td align="center" valign="middle" rowspan="1" colspan="1">N/A</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" colspan="4" rowspan="1">Symptom ratings</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PSQI</td><td align="center" valign="middle" rowspan="1" colspan="1">7.4 ± 5.1 (0–17)</td><td align="center" valign="bottom" rowspan="1" colspan="1">5.2 ± 3.5 (1–12)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.17</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RPQ</td><td align="center" valign="middle" rowspan="1" colspan="1">14.2 ± 15.1 (0–48)</td><td align="center" valign="bottom" rowspan="1" colspan="1">8.6 ± 7.9 (0–26)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Total number of symptoms</td><td align="center" valign="top" rowspan="1" colspan="1">4.3 ± 4.8 (0–14)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.0 ± 2.4 (0–8)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" valign="bottom" colspan="4" rowspan="1">Glymphatic imaging markers</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">WM-ePVS (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.40 ± 0.18</td><td align="center" valign="middle" rowspan="1" colspan="1">0.39 ± 0.18</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.90</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">BG-PVS (%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.48 ± 0.21</td><td align="center" valign="top" rowspan="1" colspan="1">0.59 ± 0.22</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.13</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">ALPS Index</td><td align="center" valign="middle" rowspan="1" colspan="1">1.49 ± 0.14</td><td align="center" valign="middle" rowspan="1" colspan="1">1.51 ± 0.10</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.59</td></tr></tbody></table><table-wrap-foot><p>Values shown are Mean ± SD, with ranges or percentage in (). Race includes White (W), Black or African American (B), Asian (A), and Other (O). PSQI is the global PSQI score using the Pittsburgh Sleep Quality Questionnaire. RPQ is the total scores from the Rivermead Post Concussion Symptoms questionnaire. Total number of symptoms was counted when reported as at least mild symptoms (RPQ ratings ≥2). WM-ePVS is the white matter ePVS burden. BG-PVS is the basal ganglia ePVS burden. Significant <italic toggle="yes">p</italic>-values (<italic toggle="yes">p</italic> &lt; 0.05) were shown in bold with *. MVC, Motor Vehicle Collision.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Socio-demographic, symptoms, and imaging measures for the two control groups (orthopedic control, OC, and healthy controls, HC).</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th align="center" valign="top">Orthopedic control</th><th align="center" valign="top">Healthy control</th><th align="center" valign="top">p-value (OC vs. HC)</th></tr></thead><tbody><tr><td align="left" valign="bottom">N</td><td align="center" valign="bottom">19</td><td align="center" valign="bottom">18</td><td/></tr><tr><td align="left" valign="middle">Age (yrs)</td><td align="center" valign="middle">37.3 ± 13.8 (19–60)</td><td align="center" valign="middle">35.5 ± 12.3 (18–56)</td><td align="center" valign="middle">0.79</td></tr><tr><td align="left" valign="bottom">Sex (Male)</td><td align="center" valign="bottom">12 (63%)</td><td align="center" valign="bottom">5 (28%)</td><td align="center" valign="bottom">0.043*</td></tr><tr><td align="left" valign="middle">Education (yrs)</td><td align="center" valign="middle">13.4 ± 1.9 (11–18)</td><td align="center" valign="middle">17.1 ± 3.4 (10–24)</td><td align="center" valign="middle">0.0003*</td></tr><tr><td align="left" valign="middle">Race (W/B/A/O)</td><td align="center" valign="middle">7/10/1/1</td><td align="center" valign="middle">9/7/2/0</td><td align="center" valign="middle">0.55</td></tr><tr><td align="left" valign="middle">Body Mass Index (BMI)</td><td align="center" valign="middle">28.3 ± 6.7 (20.7–53.7)</td><td align="center" valign="middle">28.7 ± 9.8 (19.5–53.7)</td><td align="center" valign="middle">0.87</td></tr><tr><td align="left" valign="middle">Days post injury</td><td align="center" valign="middle">13.8 ± 6.9 (6–29)</td><td align="center" valign="middle">N/A</td><td/></tr><tr><td align="left" valign="middle" colspan="4">Symptom ratings</td></tr><tr><td align="left" valign="middle">PSQI</td><td align="center" valign="middle">7.4 ± 5.1 (0–17)</td><td align="center" valign="bottom">5.2 ± 3.5 (1–12)</td><td align="center" valign="middle">0.17</td></tr><tr><td align="left" valign="middle">RPQ</td><td align="center" valign="middle">14.2 ± 15.1 (0–48)</td><td align="center" valign="bottom">8.6 ± 7.9 (0–26)</td><td align="center" valign="middle">0.22</td></tr><tr><td align="left" valign="bottom">Total number of symptoms</td><td align="center" valign="top">4.3 ± 4.8 (0–14)</td><td align="center" valign="middle">2.0 ± 2.4 (0–8)</td><td align="center" valign="middle">0.12</td></tr><tr><td align="left" valign="bottom" colspan="4">Glymphatic imaging markers</td></tr><tr><td align="left" valign="bottom">WM-ePVS (%)</td><td align="center" valign="middle">0.40 ± 0.18</td><td align="center" valign="middle">0.39 ± 0.18</td><td align="center" valign="bottom">0.90</td></tr><tr><td align="left" valign="bottom">BG-PVS (%)</td><td align="center" valign="top">0.48 ± 0.21</td><td align="center" valign="top">0.59 ± 0.22</td><td align="center" valign="bottom">0.13</td></tr><tr><td align="left" valign="bottom">ALPS Index</td><td align="center" valign="middle">1.49 ± 0.14</td><td align="center" valign="middle">1.51 ± 0.10</td><td align="center" valign="bottom">0.59</td></tr></tbody></table></div>Values shown are Mean ± SD, with ranges or percentage in (). Race includes White (W), Black or African American (B), Asian (A), and Other (O). PSQI is the global PSQI score using the Pittsburgh Sleep Quality Questionnaire. RPQ is the total scores from the Rivermead Post Concussion Symptoms questionnaire. Total number of symptoms was counted when reported as at least mild symptoms (RPQ ratings ≥2). WM-ePVS is the white matter ePVS burden. BG-PVS is the basal ganglia ePVS burden. Significant p-values (p &lt; 0.05) were shown in bold with *. MVC, Motor Vehicle Collision.</transformed-table></extracted-table><extracted-table><table-id>tab2</table-id><table-label>Table 2</table-label><table-caption>Socio-demographic, symptoms, and imaging measures for control and mTBI patients at two visits (14Day and 6–12Mon).</table-caption><table-wrap-foot>Values shown are Mean ± SD, with ranges or percentage in (). Positive CT or MRI findings are based on admission CT and clinical MRI sequences. Race includes White (W), Black or African American (B), Asian (A), and Other (O). PSQI is the global PSQI score using the Pittsburgh Sleep Quality Questionnaire. RPQ is the total scores from the Rivermead Post Concussion Symptoms questionnaire. Total number of symptoms was counted when reported as at least mild symptoms (RPQ ratings ≥2). WM-ePVS is the white matter ePVS burden. BG-PVS is the basal ganglia ePVS burden. Significant p-values (p &lt; 0.05) were shown in bold with*. MVC, Motor Vehicle Collision.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="tab2" orientation="portrait"><label>Table 2</label><caption><p>Socio-demographic, symptoms, and imaging measures for control and mTBI patients at two visits (14Day and 6–12Mon).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" valign="top" rowspan="1" colspan="1">Control</th><th align="center" valign="top" colspan="2" rowspan="1">mTBI</th><th align="center" valign="top" colspan="2" rowspan="1"><italic toggle="yes">p</italic>-value (Control vs. mTBI)</th></tr></thead><tbody><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">N</italic></td><td align="center" valign="middle" rowspan="1" colspan="1">37</td><td align="center" valign="bottom" colspan="2" rowspan="1">44</td><td colspan="2" rowspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Age (yrs)</td><td align="center" valign="middle" rowspan="1" colspan="1">36.7 ± 12.9 (18–60)</td><td align="center" valign="bottom" colspan="2" rowspan="1">34.5 ± 11.3 (18–59)</td><td align="center" valign="middle" colspan="2" rowspan="1">0.41</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Sex (Male)</td><td align="center" valign="middle" rowspan="1" colspan="1">17 (38%)</td><td align="center" valign="bottom" colspan="2" rowspan="1">24 (55%)</td><td align="center" valign="middle" colspan="2" rowspan="1">0.51</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Education (yrs)</td><td align="center" valign="middle" rowspan="1" colspan="1">15.2 ± 3.3 (10–24)</td><td align="center" valign="bottom" colspan="2" rowspan="1">14.2 ± 2.8 (9–24)</td><td align="center" valign="middle" colspan="2" rowspan="1">0.17</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Race (W/B/A/O)</td><td align="center" valign="middle" rowspan="1" colspan="1">16/17/3/1</td><td align="center" valign="bottom" colspan="2" rowspan="1">18/17/2/7</td><td align="center" valign="middle" colspan="2" rowspan="1">0.23</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Body Mass Index (BMI)</td><td align="center" valign="middle" rowspan="1" colspan="1">28.5 ± 8.2 (19.5–53.7)</td><td align="center" valign="bottom" colspan="2" rowspan="1">27.6 ± 6.0 (17.4–42.7)</td><td align="center" valign="middle" colspan="2" rowspan="1">0.56</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Positive CT or MRI</td><td align="center" valign="bottom" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="bottom" colspan="2" rowspan="1">20 (45%)</td><td colspan="2" rowspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Admission GCS</td><td align="center" valign="bottom" rowspan="1" colspan="1">N/A</td><td align="center" valign="bottom" colspan="2" rowspan="1">14.7 ± 0.5 (13–15)</td><td colspan="2" rowspan="1"/></tr><tr><td align="left" valign="bottom" colspan="6" rowspan="1">Injury mechanism</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">MVC</td><td rowspan="1" colspan="1"/><td align="center" valign="bottom" colspan="2" rowspan="1">28 (64%)</td><td colspan="2" rowspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Assault</td><td rowspan="1" colspan="1"/><td align="center" valign="bottom" colspan="2" rowspan="1">4 (9%)</td><td colspan="2" rowspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Fall</td><td rowspan="1" colspan="1"/><td align="center" valign="bottom" colspan="2" rowspan="1">8 (18%)</td><td colspan="2" rowspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Sports/Recreational</td><td rowspan="1" colspan="1"/><td align="center" valign="bottom" colspan="2" rowspan="1">4 (9%)</td><td colspan="2" rowspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1">14Day</td><td align="center" valign="bottom" rowspan="1" colspan="1">6–12Mon</td><td align="center" valign="bottom" rowspan="1" colspan="1">14Day</td><td align="center" valign="bottom" rowspan="1" colspan="1">6–12Mon</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Days post injury</td><td align="center" valign="bottom" rowspan="1" colspan="1">N/A</td><td align="center" valign="middle" rowspan="1" colspan="1">13.8 ± 8.1</td><td align="center" valign="middle" rowspan="1" colspan="1">306 ± 97</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="center" valign="middle" rowspan="1" colspan="1">(2–45)</td><td align="center" valign="middle" rowspan="1" colspan="1">(157–508)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" colspan="6" rowspan="1">Symptom ratings</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PSQI</td><td align="center" valign="middle" rowspan="1" colspan="1">6.5 ± 4.5 (0–17)</td><td align="center" valign="bottom" rowspan="1" colspan="1">6.1 ± 3.0 (1–14)</td><td align="center" valign="bottom" rowspan="1" colspan="1">6.9 ± 3.5 (0–14)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.72</td><td align="center" valign="middle" rowspan="1" colspan="1">0.67</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RPQ</td><td align="center" valign="middle" rowspan="1" colspan="1">11.8 ± 12.6 (0–48)</td><td align="center" valign="bottom" rowspan="1" colspan="1">21.4 ± 18.4 (0–85)</td><td align="center" valign="bottom" rowspan="1" colspan="1">21.7 ± 16.5 (0–73)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.014*</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.006*</bold></td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Total number of symptoms</td><td align="center" valign="top" rowspan="1" colspan="1">3.3 ± 4.0 (0–14)</td><td align="center" valign="middle" rowspan="1" colspan="1">7.1 ± 5.5 (0–21)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.8 ± 6.2 (0–22)</td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.0015*</bold></td><td align="center" valign="middle" rowspan="1" colspan="1"><bold>0.0064*</bold></td></tr><tr><td align="left" valign="bottom" colspan="4" rowspan="1">Glymphatic imaging markers</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">WM-ePVS (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.40 ± 0.18</td><td align="center" valign="middle" rowspan="1" colspan="1">0.35 ± 0.26</td><td align="center" valign="middle" rowspan="1" colspan="1">0.38 ± 0.30</td><td align="center" valign="middle" rowspan="1" colspan="1">0.38</td><td align="center" valign="middle" rowspan="1" colspan="1">0.68</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">BG-PVS (%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.53 ± 0.22</td><td align="center" valign="top" rowspan="1" colspan="1">0.50 ± 0.30</td><td align="center" valign="top" rowspan="1" colspan="1">0.60 ± 0.41</td><td align="center" valign="middle" rowspan="1" colspan="1">0.53</td><td align="center" valign="middle" rowspan="1" colspan="1">0.40</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">ALPS Index</td><td align="center" valign="middle" rowspan="1" colspan="1">1.51 ± 0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">1.52 ± 0.13</td><td align="center" valign="middle" rowspan="1" colspan="1">1.50 ± 0.13</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.66</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.82</td></tr></tbody></table><table-wrap-foot><p>Values shown are Mean ± SD, with ranges or percentage in (). Positive CT or MRI findings are based on admission CT and clinical MRI sequences. Race includes White (W), Black or African American (B), Asian (A), and Other (O). PSQI is the global PSQI score using the Pittsburgh Sleep Quality Questionnaire. RPQ is the total scores from the Rivermead Post Concussion Symptoms questionnaire. Total number of symptoms was counted when reported as at least mild symptoms (RPQ ratings ≥2). WM-ePVS is the white matter ePVS burden. BG-PVS is the basal ganglia ePVS burden. Significant <italic toggle="yes">p</italic>-values (<italic toggle="yes">p</italic> &lt; 0.05) were shown in bold with*. MVC, Motor Vehicle Collision.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Socio-demographic, symptoms, and imaging measures for control and mTBI patients at two visits (14Day and 6–12Mon).</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th/><th align="center" valign="top">Control</th><th align="center" valign="top" colspan="2">mTBI</th><th align="center" valign="top" colspan="2">p-value (Control vs. mTBI)</th></tr></thead><tbody><tr><td align="left" valign="bottom">N</td><td align="center" valign="middle">37</td><td align="center" valign="bottom" colspan="2">44</td><td colspan="2"/></tr><tr><td align="left" valign="bottom">Age (yrs)</td><td align="center" valign="middle">36.7 ± 12.9 (18–60)</td><td align="center" valign="bottom" colspan="2">34.5 ± 11.3 (18–59)</td><td align="center" valign="middle" colspan="2">0.41</td></tr><tr><td align="left" valign="bottom">Sex (Male)</td><td align="center" valign="middle">17 (38%)</td><td align="center" valign="bottom" colspan="2">24 (55%)</td><td align="center" valign="middle" colspan="2">0.51</td></tr><tr><td align="left" valign="middle">Education (yrs)</td><td align="center" valign="middle">15.2 ± 3.3 (10–24)</td><td align="center" valign="bottom" colspan="2">14.2 ± 2.8 (9–24)</td><td align="center" valign="middle" colspan="2">0.17</td></tr><tr><td align="left" valign="middle">Race (W/B/A/O)</td><td align="center" valign="middle">16/17/3/1</td><td align="center" valign="bottom" colspan="2">18/17/2/7</td><td align="center" valign="middle" colspan="2">0.23</td></tr><tr><td align="left" valign="middle">Body Mass Index (BMI)</td><td align="center" valign="middle">28.5 ± 8.2 (19.5–53.7)</td><td align="center" valign="bottom" colspan="2">27.6 ± 6.0 (17.4–42.7)</td><td align="center" valign="middle" colspan="2">0.56</td></tr><tr><td align="left" valign="bottom">Positive CT or MRI</td><td align="center" valign="bottom">0 (0%)</td><td align="center" valign="bottom" colspan="2">20 (45%)</td><td colspan="2"/></tr><tr><td align="left" valign="bottom">Admission GCS</td><td align="center" valign="bottom">N/A</td><td align="center" valign="bottom" colspan="2">14.7 ± 0.5 (13–15)</td><td colspan="2"/></tr><tr><td align="left" valign="bottom" colspan="6">Injury mechanism</td></tr><tr><td align="left" valign="bottom">MVC</td><td/><td align="center" valign="bottom" colspan="2">28 (64%)</td><td colspan="2"/></tr><tr><td align="left" valign="bottom">Assault</td><td/><td align="center" valign="bottom" colspan="2">4 (9%)</td><td colspan="2"/></tr><tr><td align="left" valign="bottom">Fall</td><td/><td align="center" valign="bottom" colspan="2">8 (18%)</td><td colspan="2"/></tr><tr><td align="left" valign="bottom">Sports/Recreational</td><td/><td align="center" valign="bottom" colspan="2">4 (9%)</td><td colspan="2"/></tr><tr><td/><td/><td align="center" valign="bottom">14Day</td><td align="center" valign="bottom">6–12Mon</td><td align="center" valign="bottom">14Day</td><td align="center" valign="bottom">6–12Mon</td></tr><tr><td align="left" valign="bottom">Days post injury</td><td align="center" valign="bottom">N/A</td><td align="center" valign="middle">13.8 ± 8.1</td><td align="center" valign="middle">306 ± 97</td><td/><td/></tr><tr><td/><td/><td align="center" valign="middle">(2–45)</td><td align="center" valign="middle">(157–508)</td><td/><td/></tr><tr><td align="left" valign="middle" colspan="6">Symptom ratings</td></tr><tr><td align="left" valign="middle">PSQI</td><td align="center" valign="middle">6.5 ± 4.5 (0–17)</td><td align="center" valign="bottom">6.1 ± 3.0 (1–14)</td><td align="center" valign="bottom">6.9 ± 3.5 (0–14)</td><td align="center" valign="middle">0.72</td><td align="center" valign="middle">0.67</td></tr><tr><td align="left" valign="middle">RPQ</td><td align="center" valign="middle">11.8 ± 12.6 (0–48)</td><td align="center" valign="bottom">21.4 ± 18.4 (0–85)</td><td align="center" valign="bottom">21.7 ± 16.5 (0–73)</td><td align="center" valign="middle">0.014*</td><td align="center" valign="middle">0.006*</td></tr><tr><td align="left" valign="bottom">Total number of symptoms</td><td align="center" valign="top">3.3 ± 4.0 (0–14)</td><td align="center" valign="middle">7.1 ± 5.5 (0–21)</td><td align="center" valign="middle">6.8 ± 6.2 (0–22)</td><td align="center" valign="middle">0.0015*</td><td align="center" valign="middle">0.0064*</td></tr><tr><td align="left" valign="bottom" colspan="4">Glymphatic imaging markers</td><td/><td/></tr><tr><td align="left" valign="bottom">WM-ePVS (%)</td><td align="center" valign="middle">0.40 ± 0.18</td><td align="center" valign="middle">0.35 ± 0.26</td><td align="center" valign="middle">0.38 ± 0.30</td><td align="center" valign="middle">0.38</td><td align="center" valign="middle">0.68</td></tr><tr><td align="left" valign="bottom">BG-PVS (%)</td><td align="center" valign="top">0.53 ± 0.22</td><td align="center" valign="top">0.50 ± 0.30</td><td align="center" valign="top">0.60 ± 0.41</td><td align="center" valign="middle">0.53</td><td align="center" valign="middle">0.40</td></tr><tr><td align="left" valign="bottom">ALPS Index</td><td align="center" valign="middle">1.51 ± 0.12</td><td align="center" valign="middle">1.52 ± 0.13</td><td align="center" valign="middle">1.50 ± 0.13</td><td align="center" valign="bottom">0.66</td><td align="center" valign="bottom">0.82</td></tr></tbody></table></div>Values shown are Mean ± SD, with ranges or percentage in (). Positive CT or MRI findings are based on admission CT and clinical MRI sequences. Race includes White (W), Black or African American (B), Asian (A), and Other (O). PSQI is the global PSQI score using the Pittsburgh Sleep Quality Questionnaire. RPQ is the total scores from the Rivermead Post Concussion Symptoms questionnaire. Total number of symptoms was counted when reported as at least mild symptoms (RPQ ratings ≥2). WM-ePVS is the white matter ePVS burden. BG-PVS is the basal ganglia ePVS burden. Significant p-values (p &lt; 0.05) were shown in bold with*. MVC, Motor Vehicle Collision.</transformed-table></extracted-table><extracted-table><table-id>tab3</table-id><table-label>Table 3</table-label><table-caption>Sicio-demographic, symptoms, and imaging measures for mTBI patients with and without memory problems at two visits (14Day and 6–12Mon).</table-caption><table-wrap-foot>The existence of memory problems was defined as RPQ ratings ≥ 2 at the 14Day visit. Values shown are Mean ± SD, with ranges or percentage in ( ). Positive CT or MRI findings are based on admission CT and clinical MRI sequences. Race includes White (W), Black or African American (B), Asian (A), and Other (O). PSQI is the global PSQI score using the Pittsburgh Sleep Quality Questionnaire. RPQ is the total scores from the Rivermead Post Concussion Symptoms questionnaire. Total Number of Symptoms was counted when reported as at least mild symptoms (RPQ ratings ≥ 2). WM-ePVS is the white matter ePVS burden. BG-PVS is the basal ganglia ePVS burden. Same mTBI patients were included for both visits, therefore demographic information stays the same. Significant p-values (p &lt; 0.05) were shown in bold with *. BMI, Body Mass Index. MVC, Motor Vehicle Collision.</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="tab3" orientation="portrait"><label>Table 3</label><caption><p>Sicio-demographic, symptoms, and imaging measures for mTBI patients with and without memory problems at two visits (14Day and 6–12Mon).</p></caption><table frame="hsides" rules="groups"><tbody><tr><td rowspan="1" colspan="1"/><td align="left" valign="top" colspan="2" rowspan="1">No Memory Prob at 14Day</td><td align="left" valign="top" colspan="2" rowspan="1">With Memory Prob at 14Day</td><td align="left" valign="top" colspan="2" rowspan="1">Group Differences (<italic toggle="yes">p</italic>-value)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">N</td><td align="center" valign="top" colspan="2" rowspan="1">21</td><td align="center" valign="top" colspan="2" rowspan="1">23</td><td colspan="2" rowspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (yrs)</td><td align="center" valign="top" colspan="2" rowspan="1">35.3 ± 11.2 (19 – 59)</td><td align="center" valign="top" colspan="2" rowspan="1">33.9 ± 11.5 (18 – 53)</td><td align="center" valign="top" colspan="2" rowspan="1">0.68</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex (Male)</td><td align="center" valign="top" colspan="2" rowspan="1">13 (62%)</td><td align="center" valign="top" colspan="2" rowspan="1">11 (48%)</td><td align="center" valign="top" colspan="2" rowspan="1">0.35</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Education (yrs)</td><td align="center" valign="top" colspan="2" rowspan="1">14.4 ± 3.2 (9 – 24)</td><td align="center" valign="top" colspan="2" rowspan="1">14.1 ± 2.4 (9 – 18)</td><td align="center" valign="top" colspan="2" rowspan="1">0.74</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Race (W/B/A/O)</td><td align="center" valign="top" colspan="2" rowspan="1">9/8/2/0</td><td align="center" valign="top" colspan="2" rowspan="1">9/9/0/5</td><td align="center" valign="top" colspan="2" rowspan="1">0.35</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI</td><td align="center" valign="top" colspan="2" rowspan="1">27.1 ± 4.8 (17.6 – 40.3)</td><td align="center" valign="top" colspan="2" rowspan="1">28.0 ± 7.1 (17.4 – 42.7)</td><td align="center" valign="top" colspan="2" rowspan="1">0.65</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Positive CT or MRI</td><td align="center" valign="top" colspan="2" rowspan="1">13 (62%)</td><td align="center" valign="top" colspan="2" rowspan="1">7 (30%)</td><td align="center" valign="top" colspan="2" rowspan="1">0.067</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Admission GCS</td><td align="center" valign="top" colspan="2" rowspan="1">14.7 ± 0.7 (13 – 15)</td><td align="center" valign="top" colspan="2" rowspan="1">14.9 ± 0.4 (14 – 15)</td><td align="center" valign="top" colspan="2" rowspan="1">0.25</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Injury mechanism</td><td colspan="2" rowspan="1"/><td colspan="2" rowspan="1"/><td align="center" valign="top" colspan="2" rowspan="1">0.58</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MVC</td><td align="center" valign="top" colspan="2" rowspan="1">11 (52%)</td><td align="center" valign="top" colspan="2" rowspan="1">17 (74%)</td><td colspan="2" rowspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Assault</td><td align="center" valign="top" colspan="2" rowspan="1">2 (10%)</td><td align="center" valign="top" colspan="2" rowspan="1">2 (9%)</td><td colspan="2" rowspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fall</td><td align="center" valign="top" colspan="2" rowspan="1">5 (24%)</td><td align="center" valign="top" colspan="2" rowspan="1">3 (13%)</td><td colspan="2" rowspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sports/recreational</td><td align="center" valign="top" colspan="2" rowspan="1">3 (14%)</td><td align="center" valign="top" colspan="2" rowspan="1">1 (4%)</td><td colspan="2" rowspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">14Day</td><td align="center" valign="top" rowspan="1" colspan="1">6-12Mon</td><td align="center" valign="top" rowspan="1" colspan="1">14Day</td><td align="center" valign="top" rowspan="1" colspan="1">6-12Mon</td><td align="center" valign="top" rowspan="1" colspan="1">14Day</td><td align="center" valign="top" rowspan="1" colspan="1">6-12Mon</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Days post injury</td><td align="center" valign="top" rowspan="1" colspan="1">12.8 ± 9.1 (2 – 45)</td><td align="center" valign="top" rowspan="1" colspan="1">14.6 ± 7.1 (3 – 34)</td><td align="center" valign="top" rowspan="1" colspan="1">306 ± 99 (157 – 440)</td><td align="center" valign="top" rowspan="1" colspan="1">305 ± 97 (173 – 508)</td><td align="center" valign="top" rowspan="1" colspan="1">0.47</td><td align="center" valign="top" rowspan="1" colspan="1">0.95</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Symptom ratings</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PSQI</td><td align="center" valign="top" rowspan="1" colspan="1">5.7 ± 3.2 (1 – 14)</td><td align="center" valign="top" rowspan="1" colspan="1">6.7 ± 4.0 (0 – 14)</td><td align="center" valign="top" rowspan="1" colspan="1">6.5 ± 2.8 (3 – 13)</td><td align="center" valign="top" rowspan="1" colspan="1">6.5 ± 2.8 (3 – 14)</td><td align="center" valign="top" rowspan="1" colspan="1">0.42</td><td align="center" valign="top" rowspan="1" colspan="1">0.72</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">RPQ</td><td align="center" valign="top" rowspan="1" colspan="1">7.8 ± 7.1 (0 – 21)</td><td align="center" valign="top" rowspan="1" colspan="1">15.1 ± 15.6 (0 – 46)</td><td align="center" valign="top" rowspan="1" colspan="1">33.8 ± 16.7 (15 – 85)</td><td align="center" valign="top" rowspan="1" colspan="1">27.2 ± 15.4 (4 – 73)</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>&lt; 0.0001*</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0.02*</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total Number of Symptoms</td><td align="center" valign="top" rowspan="1" colspan="1">2.7 ± 2.5 (0 – 7)</td><td align="center" valign="top" rowspan="1" colspan="1">4.0 ± 4.8 (0 – 15)</td><td align="center" valign="top" rowspan="1" colspan="1">11.0 ± 4.3 (6 – 21)</td><td align="center" valign="top" rowspan="1" colspan="1">9.3 ± 6.3 (1 – 22)</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>&lt; 0.0001*</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0.004*</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Glymphatic imaging markers</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">WM-ePVS (%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.27 ± 0.16</td><td align="center" valign="top" rowspan="1" colspan="1">0.28 ± 0.17</td><td align="center" valign="top" rowspan="1" colspan="1">0.44 ± 0.31</td><td align="center" valign="top" rowspan="1" colspan="1">0.47 ± 0.36</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0.016*</bold></td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0.014*</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BG-PVS (%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.43 ± 0.27</td><td align="center" valign="top" rowspan="1" colspan="1">0.53 ± 0.32</td><td align="center" valign="top" rowspan="1" colspan="1">0.56 ± 0.32</td><td align="center" valign="top" rowspan="1" colspan="1">0.76 ± 0.64</td><td align="center" valign="top" rowspan="1" colspan="1">0.17</td><td align="center" valign="top" rowspan="1" colspan="1">0.14</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ALPS Index</td><td align="center" valign="top" rowspan="1" colspan="1">1.53 ± 0.13</td><td align="center" valign="top" rowspan="1" colspan="1">1.49 ± 0.14</td><td align="center" valign="top" rowspan="1" colspan="1">1.50 ± 0.13</td><td align="center" valign="top" rowspan="1" colspan="1">1.50 ± 0.12</td><td align="center" valign="top" rowspan="1" colspan="1">0.44</td><td align="center" valign="top" rowspan="1" colspan="1">0.82</td></tr></tbody></table><table-wrap-foot><p>The existence of memory problems was defined as RPQ ratings ≥ 2 at the 14Day visit. Values shown are Mean ± SD, with ranges or percentage in ( ). Positive CT or MRI findings are based on admission CT and clinical MRI sequences. Race includes White (W), Black or African American (B), Asian (A), and Other (O). PSQI is the global PSQI score using the Pittsburgh Sleep Quality Questionnaire. RPQ is the total scores from the Rivermead Post Concussion Symptoms questionnaire. Total Number of Symptoms was counted when reported as at least mild symptoms (RPQ ratings ≥ 2). WM-ePVS is the white matter ePVS burden. BG-PVS is the basal ganglia ePVS burden. Same mTBI patients were included for both visits, therefore demographic information stays the same. Significant <italic toggle="yes">p</italic>-values (<italic toggle="yes">p</italic> &lt; 0.05) were shown in bold with *. BMI, Body Mass Index. MVC, Motor Vehicle Collision.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Sicio-demographic, symptoms, and imaging measures for mTBI patients with and without memory problems at two visits (14Day and 6–12Mon).</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><tbody><tr><td/><td align="left" valign="top" colspan="2">No Memory Prob at 14Day</td><td align="left" valign="top" colspan="2">With Memory Prob at 14Day</td><td align="left" valign="top" colspan="2">Group Differences (p-value)</td></tr><tr><td align="left" valign="top">N</td><td align="center" valign="top" colspan="2">21</td><td align="center" valign="top" colspan="2">23</td><td colspan="2"/></tr><tr><td align="left" valign="top">Age (yrs)</td><td align="center" valign="top" colspan="2">35.3 ± 11.2 (19 – 59)</td><td align="center" valign="top" colspan="2">33.9 ± 11.5 (18 – 53)</td><td align="center" valign="top" colspan="2">0.68</td></tr><tr><td align="left" valign="top">Sex (Male)</td><td align="center" valign="top" colspan="2">13 (62%)</td><td align="center" valign="top" colspan="2">11 (48%)</td><td align="center" valign="top" colspan="2">0.35</td></tr><tr><td align="left" valign="top">Education (yrs)</td><td align="center" valign="top" colspan="2">14.4 ± 3.2 (9 – 24)</td><td align="center" valign="top" colspan="2">14.1 ± 2.4 (9 – 18)</td><td align="center" valign="top" colspan="2">0.74</td></tr><tr><td align="left" valign="top">Race (W/B/A/O)</td><td align="center" valign="top" colspan="2">9/8/2/0</td><td align="center" valign="top" colspan="2">9/9/0/5</td><td align="center" valign="top" colspan="2">0.35</td></tr><tr><td align="left" valign="top">BMI</td><td align="center" valign="top" colspan="2">27.1 ± 4.8 (17.6 – 40.3)</td><td align="center" valign="top" colspan="2">28.0 ± 7.1 (17.4 – 42.7)</td><td align="center" valign="top" colspan="2">0.65</td></tr><tr><td align="left" valign="top">Positive CT or MRI</td><td align="center" valign="top" colspan="2">13 (62%)</td><td align="center" valign="top" colspan="2">7 (30%)</td><td align="center" valign="top" colspan="2">0.067</td></tr><tr><td align="left" valign="top">Admission GCS</td><td align="center" valign="top" colspan="2">14.7 ± 0.7 (13 – 15)</td><td align="center" valign="top" colspan="2">14.9 ± 0.4 (14 – 15)</td><td align="center" valign="top" colspan="2">0.25</td></tr><tr><td align="left" valign="top">Injury mechanism</td><td colspan="2"/><td colspan="2"/><td align="center" valign="top" colspan="2">0.58</td></tr><tr><td align="left" valign="top">MVC</td><td align="center" valign="top" colspan="2">11 (52%)</td><td align="center" valign="top" colspan="2">17 (74%)</td><td colspan="2"/></tr><tr><td align="left" valign="top">Assault</td><td align="center" valign="top" colspan="2">2 (10%)</td><td align="center" valign="top" colspan="2">2 (9%)</td><td colspan="2"/></tr><tr><td align="left" valign="top">Fall</td><td align="center" valign="top" colspan="2">5 (24%)</td><td align="center" valign="top" colspan="2">3 (13%)</td><td colspan="2"/></tr><tr><td align="left" valign="top">Sports/recreational</td><td align="center" valign="top" colspan="2">3 (14%)</td><td align="center" valign="top" colspan="2">1 (4%)</td><td colspan="2"/></tr><tr><td/><td align="center" valign="top">14Day</td><td align="center" valign="top">6-12Mon</td><td align="center" valign="top">14Day</td><td align="center" valign="top">6-12Mon</td><td align="center" valign="top">14Day</td><td align="center" valign="top">6-12Mon</td></tr><tr><td align="left" valign="top">Days post injury</td><td align="center" valign="top">12.8 ± 9.1 (2 – 45)</td><td align="center" valign="top">14.6 ± 7.1 (3 – 34)</td><td align="center" valign="top">306 ± 99 (157 – 440)</td><td align="center" valign="top">305 ± 97 (173 – 508)</td><td align="center" valign="top">0.47</td><td align="center" valign="top">0.95</td></tr><tr><td align="left" valign="top">Symptom ratings</td></tr><tr><td align="left" valign="top">PSQI</td><td align="center" valign="top">5.7 ± 3.2 (1 – 14)</td><td align="center" valign="top">6.7 ± 4.0 (0 – 14)</td><td align="center" valign="top">6.5 ± 2.8 (3 – 13)</td><td align="center" valign="top">6.5 ± 2.8 (3 – 14)</td><td align="center" valign="top">0.42</td><td align="center" valign="top">0.72</td></tr><tr><td align="left" valign="top">RPQ</td><td align="center" valign="top">7.8 ± 7.1 (0 – 21)</td><td align="center" valign="top">15.1 ± 15.6 (0 – 46)</td><td align="center" valign="top">33.8 ± 16.7 (15 – 85)</td><td align="center" valign="top">27.2 ± 15.4 (4 – 73)</td><td align="center" valign="top">&lt; 0.0001*</td><td align="center" valign="top">0.02*</td></tr><tr><td align="left" valign="top">Total Number of Symptoms</td><td align="center" valign="top">2.7 ± 2.5 (0 – 7)</td><td align="center" valign="top">4.0 ± 4.8 (0 – 15)</td><td align="center" valign="top">11.0 ± 4.3 (6 – 21)</td><td align="center" valign="top">9.3 ± 6.3 (1 – 22)</td><td align="center" valign="top">&lt; 0.0001*</td><td align="center" valign="top">0.004*</td></tr><tr><td align="left" valign="top">Glymphatic imaging markers</td></tr><tr><td align="left" valign="top">WM-ePVS (%)</td><td align="center" valign="top">0.27 ± 0.16</td><td align="center" valign="top">0.28 ± 0.17</td><td align="center" valign="top">0.44 ± 0.31</td><td align="center" valign="top">0.47 ± 0.36</td><td align="center" valign="top">0.016*</td><td align="center" valign="top">0.014*</td></tr><tr><td align="left" valign="top">BG-PVS (%)</td><td align="center" valign="top">0.43 ± 0.27</td><td align="center" valign="top">0.53 ± 0.32</td><td align="center" valign="top">0.56 ± 0.32</td><td align="center" valign="top">0.76 ± 0.64</td><td align="center" valign="top">0.17</td><td align="center" valign="top">0.14</td></tr><tr><td align="left" valign="top">ALPS Index</td><td align="center" valign="top">1.53 ± 0.13</td><td align="center" valign="top">1.49 ± 0.14</td><td align="center" valign="top">1.50 ± 0.13</td><td align="center" valign="top">1.50 ± 0.12</td><td align="center" valign="top">0.44</td><td align="center" valign="top">0.82</td></tr></tbody></table></div>The existence of memory problems was defined as RPQ ratings ≥ 2 at the 14Day visit. Values shown are Mean ± SD, with ranges or percentage in ( ). Positive CT or MRI findings are based on admission CT and clinical MRI sequences. Race includes White (W), Black or African American (B), Asian (A), and Other (O). PSQI is the global PSQI score using the Pittsburgh Sleep Quality Questionnaire. RPQ is the total scores from the Rivermead Post Concussion Symptoms questionnaire. Total Number of Symptoms was counted when reported as at least mild symptoms (RPQ ratings ≥ 2). WM-ePVS is the white matter ePVS burden. BG-PVS is the basal ganglia ePVS burden. Same mTBI patients were included for both visits, therefore demographic information stays the same. Significant p-values (p &lt; 0.05) were shown in bold with *. BMI, Body Mass Index. MVC, Motor Vehicle Collision.</transformed-table></extracted-table><extracted-table><table-id>tab4</table-id><table-label>Table 4</table-label><table-caption>Logistic regression model coefficients for Model 2 (Figure 7).</table-caption><table-wrap-foot>Among all socio-demographic and clinical information, Education and CT or MRI findings were selected to compose the best logistic model for prediction of 6–12Mon memory problem. 14Day WM-ePVS and ALPS were also significant factors (bolded with *).</table-wrap-foot><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" position="float" id="tab4" orientation="portrait"><label>Table 4</label><caption><p>Logistic regression model coefficients for Model 2 (<xref rid="fig7" ref-type="fig">Figure 7</xref>).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Coefficients</th><th align="center" valign="top" rowspan="1" colspan="1">Estimate Std.</th><th align="center" valign="top" rowspan="1" colspan="1">Error</th><th align="center" valign="top" rowspan="1" colspan="1">Z value</th><th align="center" valign="top" rowspan="1" colspan="1">Pr(&gt;|z|)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">(Intercept)</td><td align="center" valign="top" rowspan="1" colspan="1">−10.4160</td><td align="center" valign="top" rowspan="1" colspan="1">5.3262</td><td align="center" valign="top" rowspan="1" colspan="1">−1.956</td><td align="center" valign="top" rowspan="1" colspan="1">0.0505</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Education</td><td align="center" valign="top" rowspan="1" colspan="1">−0.2367</td><td align="center" valign="top" rowspan="1" colspan="1">0.1184</td><td align="center" valign="top" rowspan="1" colspan="1">−1.999</td><td align="center" valign="top" rowspan="1" colspan="1">0.0456</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CT_or_MRI (Yes)</td><td align="center" valign="top" rowspan="1" colspan="1">−1.6464</td><td align="center" valign="top" rowspan="1" colspan="1">0.8532</td><td align="center" valign="top" rowspan="1" colspan="1">−1.930</td><td align="center" valign="top" rowspan="1" colspan="1">0.0536</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">WM-ePVS</td><td align="center" valign="top" rowspan="1" colspan="1">3.5513</td><td align="center" valign="top" rowspan="1" colspan="1">1.7045</td><td align="center" valign="top" rowspan="1" colspan="1">2.084</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0.0372*</bold></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">APLS</td><td align="center" valign="top" rowspan="1" colspan="1">9.3073</td><td align="center" valign="top" rowspan="1" colspan="1">3.8718</td><td align="center" valign="top" rowspan="1" colspan="1">2.404</td><td align="center" valign="top" rowspan="1" colspan="1"><bold>0.0162*</bold></td></tr></tbody></table><table-wrap-foot><p>Among all socio-demographic and clinical information, Education and CT or MRI findings were selected to compose the best logistic model for prediction of 6–12Mon memory problem. 14Day WM-ePVS and ALPS were also significant factors (bolded with *).</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 4<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Logistic regression model coefficients for Model 2 (???).</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Coefficients</th><th align="center" valign="top">Estimate Std.</th><th align="center" valign="top">Error</th><th align="center" valign="top">Z value</th><th align="center" valign="top">Pr(&gt;|z|)</th></tr></thead><tbody><tr><td align="left" valign="top">(Intercept)</td><td align="center" valign="top">−10.4160</td><td align="center" valign="top">5.3262</td><td align="center" valign="top">−1.956</td><td align="center" valign="top">0.0505</td></tr><tr><td align="left" valign="top">Education</td><td align="center" valign="top">−0.2367</td><td align="center" valign="top">0.1184</td><td align="center" valign="top">−1.999</td><td align="center" valign="top">0.0456</td></tr><tr><td align="left" valign="top">CT_or_MRI (Yes)</td><td align="center" valign="top">−1.6464</td><td align="center" valign="top">0.8532</td><td align="center" valign="top">−1.930</td><td align="center" valign="top">0.0536</td></tr><tr><td align="left" valign="top">WM-ePVS</td><td align="center" valign="top">3.5513</td><td align="center" valign="top">1.7045</td><td align="center" valign="top">2.084</td><td align="center" valign="top">0.0372*</td></tr><tr><td align="left" valign="top">APLS</td><td align="center" valign="top">9.3073</td><td align="center" valign="top">3.8718</td><td align="center" valign="top">2.404</td><td align="center" valign="top">0.0162*</td></tr></tbody></table></div>Among all socio-demographic and clinical information, Education and CT or MRI findings were selected to compose the best logistic model for prediction of 6–12Mon memory problem. 14Day WM-ePVS and ALPS were also significant factors (bolded with *).</transformed-table></extracted-table></extracted-tables-set>